Trupanion Inc (TRUP) Director Howard E. Rubin Sells 75,000 Shares of Stock
Trupanion Inc (NYSE:TRUP) Director Howard E. Rubin sold 75,000 shares of the business’s stock in a transaction on Monday, October 3rd. The shares were sold at an average price of $16.56, for a total transaction of $1,242,000.00. Following the sale, the director now directly owns 100,000 shares of the company’s stock, valued at $1,656,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Trupanion Inc (NYSE:TRUP) opened at 15.98 on Thursday. The company’s market capitalization is $463.66 million. Trupanion Inc has a one year low of $6.27 and a one year high of $17.68. The firm has a 50-day moving average of $15.82 and a 200-day moving average of $13.95.
Trupanion (NYSE:TRUP) last issued its earnings results on Tuesday, August 2nd. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.06. The company earned $45.83 million during the quarter, compared to analyst estimates of $45.05 million. During the same period last year, the business earned ($0.17) earnings per share. The firm’s revenue was up 28.8% compared to the same quarter last year. On average, analysts anticipate that Trupanion Inc will post ($0.22) earnings per share for the current year.
A number of analysts have recently issued reports on the stock. RBC Capital Markets set a $18.00 target price on shares of Trupanion and gave the company a “buy” rating in a research note on Tuesday, September 20th. Canaccord Genuity reissued a “buy” rating and set a $19.00 target price on shares of Trupanion in a research note on Thursday, August 4th. Stifel Nicolaus upped their price objective on shares of Trupanion from $17.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, August 3rd. Zacks Investment Research lowered shares of Trupanion from a “buy” rating to a “hold” rating in a research note on Wednesday, July 27th. Finally, Lake Street Capital began coverage on shares of Trupanion in a research note on Tuesday, July 19th. They issued a “buy” rating and a $18.00 price objective for the company. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $15.75.
Hedge funds have recently modified their holdings of the company. Immersion Capital LLP acquired a new stake in shares of Trupanion during the second quarter worth about $18,374,000. Vanguard Group Inc. increased its stake in shares of Trupanion by 8.1% in the second quarter. Vanguard Group Inc. now owns 545,545 shares of the company’s stock worth $7,228,000 after buying an additional 41,036 shares during the last quarter. Grand Jean Capital Management Inc. increased its stake in shares of Trupanion by 37.0% in the first quarter. Grand Jean Capital Management Inc. now owns 277,536 shares of the company’s stock worth $2,734,000 after buying an additional 74,932 shares during the last quarter. State Street Corp increased its stake in shares of Trupanion by 50.5% in the second quarter. State Street Corp now owns 199,861 shares of the company’s stock worth $2,650,000 after buying an additional 67,026 shares during the last quarter. Finally, BlackRock Institutional Trust Company N.A. increased its stake in shares of Trupanion by 15.9% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 149,097 shares of the company’s stock worth $1,976,000 after buying an additional 20,461 shares during the last quarter.
Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.
Receive News & Stock Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related stocks with our FREE daily email newsletter.